Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer

被引:55
作者
Cserni, G
Rajtár, M
Boross, G
Sinkó, W
Svébis, M
Baltás, B
机构
[1] Univ Szeged, Sch Med, Bacs Kiskun Cty Teaching Hosp, Dept Surg Pathol, H-6000 Kecskemet, Hungary
[2] Univ Szeged, Sch Med, Bacs Kiskun Cty Teaching Hosp, Dept Nucl Med, H-6000 Kecskemet, Hungary
[3] Univ Szeged, Sch Med, Bacs Kiskun Cty Teaching Hosp, Dept Surg, H-6000 Kecskemet, Hungary
关键词
D O I
10.1007/s00268-001-0274-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
The optimal technique for sentinel lymph node biopsy (SLNB) is still debated. SLNB with peritumoral injection of Patent blue dye was performed in 129 clinically T1-T2 and NO breast cancers in 127 patients (group A). it was later replaced by combined dye and radiocolloid-guided SLNB preceded by lymphoscintigraphy in 72 breast cancer patients (group B). This study compares these two methods. All patients underwent completion axillary dissection. Means of 1.4 and 1.3 SLNs were identified in groups A and B, respectively. The mean number of non-SLNs for the whole series was 14.9 (range 5-42). The first 53 cases of lymphatic mapping (dye only) comprised the institutional learning period during which the identification rate of at least 1 SLN in 30 consecutive attempts reached 90%. The identification rate for the subsequent 76 group A patients was 92%. The accuracy rate of SLNBs for overall axillar nodal status prediction and the false-negative rate for group A patients (after excluding the learning-phase cases) were 93% and 10%, respectively. All 72 group B cases had at least one SLN identified, and only one false-negative case occurred in this group (accuracy and false-negative rates of 99% and 3%, respectively). Both the dye-only, and the combined SI,NB methods are suitable for SLN identification, but the latter works better and results in higher accuracy, a higher negative predictive value, and a lower false-negative rate. It is therefore the method of choice.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 43 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]  
Bass SS, 1999, AM SURGEON, V65, P857
[3]  
Bedrosian I, 2000, CANCER, V88, P2540, DOI 10.1002/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO
[4]  
2-A
[5]  
Bembenek A, 1999, Swiss Surg, V5, P217, DOI 10.1024/1023-9332.5.5.217
[6]   Tagging sentinel lymph nodes: a study of 100 patients with breast cancer [J].
Bobin, JY ;
Zinzindohoue, C ;
Isaac, S ;
Saadat, M ;
Roy, P .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) :569-573
[7]   Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection [J].
Borgstein, P ;
Pijpers, R ;
Comans, EF ;
van Diest, PJ ;
Boom, RP ;
Meijer, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :275-283
[8]   Functional lymphatic anatomy for sentinel node biopsy in breast cancer - Echoes from the past and the periareolar blue method [J].
Borgstein, PJ ;
Meijer, S ;
Pijpers, RJ ;
van Diest, PJ .
ANNALS OF SURGERY, 2000, 232 (01) :81-89
[9]  
CADY B, 1973, SURG CLIN N AM, V53, P313
[10]  
CAVANESE G, 2000, J SURG ONCOL, V74, P61